154 related articles for article (PubMed ID: 21286626)
1. DNA-capped nanoparticles designed for doxorubicin drug delivery.
Alexander CM; Maye MM; Dabrowiak JC
Chem Commun (Camb); 2011 Mar; 47(12):3418-20. PubMed ID: 21286626
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the drug binding properties and cytotoxicity of DNA-capped nanoparticles designed as delivery vehicles for the anticancer agents doxorubicin and actinomycin D.
Alexander CM; Dabrowiak JC; Maye MM
Bioconjug Chem; 2012 Oct; 23(10):2061-70. PubMed ID: 23043330
[TBL] [Abstract][Full Text] [Related]
3. Release of photoactivatable drugs from plasmonic nanoparticles for targeted cancer therapy.
Luo YL; Shiao YS; Huang YF
ACS Nano; 2011 Oct; 5(10):7796-804. PubMed ID: 21942498
[TBL] [Abstract][Full Text] [Related]
4. Double-shell gold nanoparticle-based DNA-carriers with poly-L-lysine binding surface.
Stobiecka M; Hepel M
Biomaterials; 2011 Apr; 32(12):3312-21. PubMed ID: 21306772
[TBL] [Abstract][Full Text] [Related]
5. A tumor mRNA-dependent gold nanoparticle-molecular beacon carrier for controlled drug release and intracellular imaging.
Qiao G; Zhuo L; Gao Y; Yu L; Li N; Tang B
Chem Commun (Camb); 2011 Jul; 47(26):7458-60. PubMed ID: 21589964
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional nanoparticles for combined doxorubicin and photothermal treatments.
Park H; Yang J; Lee J; Haam S; Choi IH; Yoo KH
ACS Nano; 2009 Oct; 3(10):2919-26. PubMed ID: 19772302
[TBL] [Abstract][Full Text] [Related]
7. Sustained in vitro release and cell uptake of doxorubicin adsorbed onto gold nanoparticles and covered by a polyelectrolyte complex layer.
Minati L; Antonini V; Torrengo S; Serra MD; Boustta M; Leclercq X; Migliaresi C; Vert M; Speranza G
Int J Pharm; 2012 Nov; 438(1-2):45-52. PubMed ID: 22959992
[TBL] [Abstract][Full Text] [Related]
8. Using temperature-sensitive smart polymers to regulate DNA-mediated nanoassembly and encoded nanocarrier drug release.
Hamner KL; Alexander CM; Coopersmith K; Reishofer D; Provenza C; Maye MM
ACS Nano; 2013 Aug; 7(8):7011-20. PubMed ID: 23899347
[TBL] [Abstract][Full Text] [Related]
9. Gold nanoparticles with a monolayer of doxorubicin-conjugated amphiphilic block copolymer for tumor-targeted drug delivery.
Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
Biomaterials; 2009 Oct; 30(30):6065-75. PubMed ID: 19674777
[TBL] [Abstract][Full Text] [Related]
10. The forthcoming applications of gold nanoparticles in drug and gene delivery systems.
Pissuwan D; Niidome T; Cortie MB
J Control Release; 2011 Jan; 149(1):65-71. PubMed ID: 20004222
[TBL] [Abstract][Full Text] [Related]
11. X-ray triggered release of doxorubicin from nanoparticle drug carriers for cancer therapy.
Starkewolf ZB; Miyachi L; Wong J; Guo T
Chem Commun (Camb); 2013 Mar; 49(25):2545-7. PubMed ID: 23423224
[TBL] [Abstract][Full Text] [Related]
12. Porphyran capped gold nanoparticles as a novel carrier for delivery of anticancer drug: in vitro cytotoxicity study.
Venkatpurwar V; Shiras A; Pokharkar V
Int J Pharm; 2011 May; 409(1-2):314-20. PubMed ID: 21376108
[TBL] [Abstract][Full Text] [Related]
13. Engineering of pectin-capped gold nanoparticles for delivery of doxorubicin to hepatocarcinoma cells: an insight into mechanism of cellular uptake.
Borker S; Pokharkar V
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):826-835. PubMed ID: 29749275
[TBL] [Abstract][Full Text] [Related]
14. Amplified plasmonic detection of DNA hybridization using doxorubicin-capped gold particles.
Spadavecchia J; Perumal R; Barras A; Lyskawa J; Woisel P; Laure W; Pradier CM; Boukherroub R; Szunerits S
Analyst; 2014 Jan; 139(1):157-64. PubMed ID: 24225546
[TBL] [Abstract][Full Text] [Related]
15. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
[TBL] [Abstract][Full Text] [Related]
16. Quaternary ammonium beta-cyclodextrin nanoparticles for enhancing doxorubicin permeability across the in vitro blood-brain barrier.
Gil ES; Li J; Xiao H; Lowe TL
Biomacromolecules; 2009 Mar; 10(3):505-16. PubMed ID: 19216528
[TBL] [Abstract][Full Text] [Related]
17. Detection of non-cross-linking interaction between DNA-modified gold nanoparticles and a DNA-modified flat gold surface using surface plasmon resonance imaging on a microchip.
Sato Y; Hosokawa K; Maeda M
Colloids Surf B Biointerfaces; 2008 Mar; 62(1):71-6. PubMed ID: 17976962
[TBL] [Abstract][Full Text] [Related]
18. Homogeneous selecting of a quadruplex-binding ligand-based gold nanoparticle fluorescence resonance energy transfer assay.
Jin Y; Li H; Bai J
Anal Chem; 2009 Jul; 81(14):5709-15. PubMed ID: 19527045
[TBL] [Abstract][Full Text] [Related]
19. Influence of a magnetic nanoparticle as a drug carrier on the activity of anticancer drugs: interactions of double stranded DNA and doxorubicin modified with a carrier.
Nowicka AM; Kowalczyk A; Donten M; Krysinski P; Stojek Z
Anal Chem; 2009 Sep; 81(17):7474-83. PubMed ID: 19663451
[TBL] [Abstract][Full Text] [Related]
20. Tracking the intracellular drug release from graphene oxide using surface-enhanced Raman spectroscopy.
Huang J; Zong C; Shen H; Cao Y; Ren B; Zhang Z
Nanoscale; 2013 Nov; 5(21):10591-8. PubMed ID: 24057012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]